Overall, these results suggested that IMPDH2 promoted oxaliplatin resistance in CRC cells through the prevention of Caspase 7, Caspase 8, Caspase 9, and PARP1 accumulation, thereby suppressing cell apoptosis. The gene discussed is PARP1; the disease is colorectal carcinoma.